Herpes Simplex Viruses 1 and 2, Varicella Zoster Virus, and Human Herpes Viruses 6, 7, and 8 in Transplant Recipients
Author:
Razonable Raymund R.
Publisher
Springer New York
Reference122 articles.
1. Schillinger JA, Xu F, Sternberg MR, et al. National seroprevalence and trends in herpes simplex virus type 1 in the United States, 1976-1994. Sex Transm Dis. 2004;31(12):753.
2. Xu F, Sternberg MR, Kottiri BJ, et al. Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States. JAMA. 2006;296(8):964.
3. Wald A, Zeh JE, Selke SA, et al. Reactivation of genital herpes simplex virus type 2 infection in asymptomatic seropositive persons. N Engl J Med. 2000;342(12):844.
4. Zhu J, Peng T, Johnston C, Phasouk K, Kask AS, Klock A, Jet a. Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection. Nature. 2013;497:494–7.
5. Styczynski J, Reusser P, Einsele H, et al. Management of HSV, VZV and EBV infections in patients with hematological malignancies and after SCT: guidelines from the second European conference on infections in leukemia. Bone Marrow Transplant. 2009;43(10):757.